Eric A. Adams - Jun 2, 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
President & CEO, Director
Signature
/s/ Brenda Edwards, attorney-in-fact for Mr. Eric A Adams
Stock symbol
INM
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/2/2022, 02:50 PM
Previous filing
Apr 18, 2022
Next filing
Nov 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -13.6K -3.88% $0.00 338K Jun 2, 2022 Common shares 13.6K $11.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$14.85 using an exchange rate of C$1.2639 = $US1.00